Menu
A screenshot of CMS' fact sheet on the 2028b IPAY drugs.
CMS announced the latest round of high-cost prescription drugs covered under Medicare Part D—and for the first time—Part B chosen for price negotiations under the IRA.

CMS Selects Drugs for Next Round of Medicare Negotiations; This Time Including Part B Products 

Shannon Young, Managing Editor 340B Report Views
The Trump administration on Tuesday announced the latest round of high-cost prescription drugs covered under Medicare Part D—and for the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

Federal Judge Rejects Third Drug Industry Challenge to Maine’s 340B Contract Pharmacy Access Law

Health Spending Package Stalls in Senate, Federal Shutdown Looms

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live